Skip Nav Destination
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
Patients with severe sepsis vary markedly in their ability to generate activated protein C
Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia
Issue Archive
December 15 2004
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
ERRATA
REVIEW IN TRANSLATIONAL HEMATOLOGY
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
Clinical Trials & Observations
Emma Morris,Kirsty Thomson,Charles Craddock,Prem Mahendra,Donald Milligan,Gordon Cook,Graeme Murray Smith,Anne Parker,Steve Schey,Rajesh Chopra,Christopher Hatton,Jane Tighe,Anne Hunter,Karl Peggs,David Linch,Anthony Goldstone,Stephen Mackinnon
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
Clinical Trials & Observations
Jerry A. Nick,Christopher D. Coldren,Mark W. Geraci,Katie R. Poch,Brian W. Fouty,James O'Brien,Michael Gruber,Simona Zarini,Robert C. Murphy,Katherine Kuhn,Don Richter,Kelly R. Kast,Edward Abraham
GENE THERAPY
Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- γc-/- mice: functional inactivation of p53 in developing T cells
Ramon Gimeno,Kees Weijer,Arie Voordouw,Christel H. Uittenbogaart,Nicolas Legrand,Nuno L. Alves,Erwin Wijnands,Bianca Blom,Hergen Spits
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Patients with severe sepsis vary markedly in their ability to generate activated protein C
Clinical Trials & Observations
Patricia C. Y. Liaw,Charles T. Esmon,Kamyar Kahnamoui,Shelley Schmidt,Sarah Kahnamoui,Gary Ferrell,Suzanne Beaudin,Jim A. Julian,Jeffrey I. Weitz,Mark Crowther,Mark Loeb,Deborah Cook
IMMUNOBIOLOGY
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation
Yinzhu Jin,Cinzia Mazza,Jacinda R. Christie,Silvia Giliani,Maurilia Fiorini,Patrizia Mella,Francesca Gandellini,Donn M. Stewart,Qili Zhu,David L. Nelson,Luigi D. Notarangelo,Hans D. Ochs
NEOPLASIA
Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy
Vahid Asnafi,Kheira Beldjord,Marta Libura,Patrick Villarese,Corrine Millien,Paola Ballerini,Emilienne Kuhlein,Marina Lafage-Pochitaloff,Eric Delabesse,Olivier Bernard,Elizabeth Macintyre
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Noopur Raje,Shaji Kumar,Teru Hideshima,Kenji Ishitsuka,Dharminder Chauhan,Constantine Mitsiades,Klaus Podar,Steven Le Gouill,Paul Richardson,Nikhil C. Munshi,David I. Stirling,Joseph H. Antin,Kenneth C. Anderson
Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy
Kambiz Fotoohi,Gerrit Jansen,Yehuda G. Assaraf,Lilah Rothem,Michal Stark,Ietje Kathmann,Jacek Gregorczyk,Godefridus J. Peters,Freidoun Albertioni
Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia
Clinical Trials & Observations
Michele Baccarani,Giovanni Martinelli,Gianantonio Rosti,Elena Trabacchi,Nicoletta Testoni,Simona Bassi,Marilina Amabile,Simona Soverini,Fausto Castagnetti,Daniela Cilloni,Barbara Izzo,Antonio de Vivo,Emanuela Messa,Francesca Bonifazi,Angela Poerio,Simona Luatti,Emilia Giugliano,Daniele Alberti,Gianluca Fincato,Domenico Russo,Fabrizio Pane,Giuseppe Saglio,for the GIMEMA Working Party on Chronic Myeloid Leukemia
PHAGOCYTES
RED CELLS
Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease
Yoko Nakano,Shigehiko Imagawa,Ken Matsumoto,Christian Stockmann,Naoshi Obara,Norio Suzuki,Takeshi Doi,Tatsuhiko Kodama,Satoru Takahashi,Toshiro Nagasawa,Masayuki Yamamoto
TRANSPLANTATION
Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs
Chiara Dell'Agnola,Zejing Wang,Rainer Storb,Stephen J. Tapscott,Christian S. Kuhr,Stephen D. Hauschka,Richard S. Lee,George E. Sale,Eustacia Zellmer,Serina Gisburne,Janet Bogan,Joe N. Kornegay,Barry J. Cooper,Theodore A. Gooley,Marie-Térèse Little
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals